BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38289597)

  • 21. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal cancer and gut microbiota studies in China.
    Wang Z; Dan W; Zhang N; Fang J; Yang Y
    Gut Microbes; 2023; 15(1):2236364. PubMed ID: 37482657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different Characteristics in Gut Microbiome between Advanced Adenoma Patients and Colorectal Cancer Patients by Metagenomic Analysis.
    Han S; Zhuang J; Pan Y; Wu W; Ding K
    Microbiol Spectr; 2022 Dec; 10(6):e0159322. PubMed ID: 36453905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and validation of an immune prognostic signature in colorectal cancer.
    Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
    Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Classification of colorectal carcinoma subtypes based on ferroptosis-associated molecular markers.
    Yue Q; Zhang Y; Wang F; Cao F; Duan X; Bai J
    World J Surg Oncol; 2022 Apr; 20(1):117. PubMed ID: 35410338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
    Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
    Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
    [No Abstract]   [Full Text] [Related]  

  • 27. Identification of host gene-microbiome associations in colorectal cancer patients using mendelian randomization.
    Xiang Y; Zhang C; Wang J; Cheng Y; Wang L; Tong Y; Yan D
    J Transl Med; 2023 Aug; 21(1):535. PubMed ID: 37563724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the gut microbiome on the genome and epigenome of colon epithelial cells: contributions to colorectal cancer development.
    Allen J; Sears CL
    Genome Med; 2019 Feb; 11(1):11. PubMed ID: 30803449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical Treatment for Colorectal Cancer Partially Restores Gut Microbiome and Metabolome Traits.
    Shiroma H; Shiba S; Erawijantari PP; Takamaru H; Yamada M; Sakamoto T; Kanemitsu Y; Mizutani S; Soga T; Saito Y; Shibata T; Fukuda S; Yachida S; Yamada T
    mSystems; 2022 Apr; 7(2):e0001822. PubMed ID: 35311577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-Omics Analysis Reveals Intratumor Microbes as Immunomodulators in Colorectal Cancer.
    Liu Z; Zhang X; Zhang H; Zhang H; Yi Z; Zhang Q; Liu Q; Liu X
    Microbiol Spectr; 2023 Feb; 11(2):e0503822. PubMed ID: 36786568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A five-immune-related genes-based prognostic signature for colorectal cancer.
    Zhu L; Wang H; Wang Z
    Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer.
    Lin D; Fan W; Zhang R; Zhao E; Li P; Zhou W; Peng J; Li L
    J Transl Med; 2021 Jun; 19(1):279. PubMed ID: 34193202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.
    John Kenneth M; Tsai HC; Fang CY; Hussain B; Chiu YC; Hsu BM
    J Adv Res; 2023 Oct; 52():45-57. PubMed ID: 36596411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Critical Genes and Five Prognostic Biomarkers Associated with Colorectal Cancer.
    Huang Z; Yang Q; Huang Z
    Med Sci Monit; 2018 Jul; 24():4625-4633. PubMed ID: 29973580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel prognostic signature of immune-related genes for patients with colorectal cancer.
    Wang J; Yu S; Chen G; Kang M; Jin X; Huang Y; Lin L; Wu D; Wang L; Chen J
    J Cell Mol Med; 2020 Aug; 24(15):8491-8504. PubMed ID: 32564470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut microbiome is more stable in males than in females during the development of colorectal cancer.
    Liao H; Li C; Ai Y; Kou Y
    J Appl Microbiol; 2021 Jul; 131(1):435-448. PubMed ID: 33245828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Hub Genes Related to Carcinogenesis and Prognosis in Colorectal Cancer Based on Integrated Bioinformatics.
    Gong B; Kao Y; Zhang C; Sun F; Gong Z; Chen J
    Mediators Inflamm; 2020; 2020():5934821. PubMed ID: 32351322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BRAF
    Trivieri N; Pracella R; Cariglia MG; Panebianco C; Parrella P; Visioli A; Giani F; Soriano AA; Barile C; Canistro G; Latiano TP; Dimitri L; Bazzocchi F; Cassano D; Vescovi AL; Pazienza V; Binda E
    J Exp Clin Cancer Res; 2020 Dec; 39(1):285. PubMed ID: 33317591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Grid2 interacting protein is a potential biomarker related to immune infiltration in colorectal cancer.
    Zhao J; Quan J; Chen W; Xie X
    Eur J Med Res; 2023 Nov; 28(1):511. PubMed ID: 37964339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
    Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
    Front Immunol; 2022; 13():887048. PubMed ID: 35784334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.